| Interstitial Cystitis (IC) | |
|
We currently are not conducting clinical trials for this category in which we are seeking participants. Please check back as this is frequently updated. Ongoing Clinical Trials Trial Status CLOSED TO ENROLLMENT Protocol Number: A0708 Sponsor: ICDX Corporation Title: A comparison of Sialic Acid content of tamm-horsfall protein (THP) in the urine of asymptomatic control subjects versus interstitial cystitis (IC) / Painful Bladder syndrome (PBS) patients. Purpose of Study This study is only open for participation in females. The primary aim of this study is to determine if there are differences in the tamm-horsfall protein (THP) in the urine of females with no symptoms versus that of female patient with confirmed interstitial cystitis (IC)/ painful bladder syndrome (PBS). For further information click here. List of Completed Trials for Interstitial Cystitis (IC) Protocol Number: JIC01 01/2003 – 09/2003 Sponsor: ICOS Title: A Phase 2, randomized, double-blind, placebo-controlled study of the safety and efficacy of RTX topical solution in the reduction of pain for patients with interstitial cystitis. Protocol Number: ANS C-04-05 05/2006 – 03/2008 Sponsor: Advanced Neuromodulation Systems Title: A pilot study to evaluate sacral nerve root stimulation for the treatment of chronic pelvic pain due to interstitial cystitis. Protocol Number: A4091010 02/2008 - 05/2009 Sponsor: Pfizer, Inc. Title: A Phase 2, 16 Week, Multicenter, Randomized, Double Blind Placebo Controlled, Parallel Group Proof Of Concept Study Evaluating The Efficacy And Safety Of Pf-04383119 For The Treatment Of Pain Associated With Interstitial Cystitis. Clinical Research Coordinators: Patricia Edwards, RN (336) 274-1114 ext. 5322 Karen Michael, RN (336) 274-1114 ext. 5328 E-mail address: research@allianceurology.com |
|
All trademarks and registered trademarks are of their respective companies.
Site powered by Medfusion, Inc.
Website Graphics by Vintage Marketing